Aim: Comparison of influenza A(H1N1) epidemic in Russia caused by pandemic virus A/ California/07/09 (H1N1) in 2009 with previous epidemics of influenza A of this subtype.
Materials And Methods: Analysis of A/California/07/09 (H1N1) epidemic was carried out in 49 cities--bases of Federal center of influenza. Parameters of this epidemic by duration, influenza and acute respiratory viral illness morbidity, hospitalization and mortality rates from laboratory confirmed influenza in the population in general and in age groups (0 - 2 years, 3 - 6 years, 7 - 14 years, 15 - 64 years, 65 years and older) were studied.
Results: A/California/07/09 (H1N1) epidemic differed from the seasonal epidemics by unusually early onset, monoetiology, wide coverage of the population of cities, longer duration and higher morbidity in the population from 7 to 64 years of age, higher rate of hospitalizations and number of lethal outcomes in the population from 15 to 64 years of age. Lower morbidity, rate of hospitalizations and number of lethal outcomes was notable in individuals older than 65 years, that is an indication of the presence of an anamnestic immunity.
Conclusion: Comparative analysis of A/ California/07/09 (H1N1) epidemic with 3 previous influenza pandemics in Russia has shown, that during this epidemic population morbidity was 2 times lower than during 1957 and 1968 pandemics, and the rate approached that of the 1977 pandemic. This epidemic differed from previous pandemics by a delay of city-megapolis and preschool aged children involvement, early onset and lower intensity of peak; lower relative rate of morbidity among adult population and higher--among school children; higher multiplicity of excessive morbidity of children compared with morbidity of people older than 15 years.
Download full-text PDF |
Source |
---|
J Avian Med Surg
January 2025
Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA,
The antipsychotic medication haloperidol has been used for many years in avian medicine as a pharmacologic therapy for refractory feather destructive behavior in pet parrots. However, despite its common use, there are no published studies evaluating its efficacy and adverse effects in psittacine birds. The goal of this study was to report the signalment, clinical presentation, dosing regimen, response to therapy, and adverse effects of companion psittacine birds prescribed oral haloperidol therapy at a single veterinary referral hospital.
View Article and Find Full Text PDFJ Perianesth Nurs
January 2025
Department of Anesthesiology, West China Second Hospital, Sichuan University, Key Laboratory of Birth Deficits and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Renmin Nanlu, Chengdu, China. Electronic address:
Purpose: This study conducted an analysis of medical malpractice litigation associated with anesthesia from 2013 to 2022, aiming to evaluate incidents of anesthesia-related safety concerns among surgical patients. The use of data derived from medical malpractice claims provided valuable insights into potential risks associated with anesthesia, contributing to the mitigation of medical malpractice and the enhancement of patient safety.
Design: A retrospective study.
J Am Coll Cardiol
December 2024
Division of Cardiology, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Background: There are no contemporary reports that highlight the national outcomes for children with congenital heart disease (CHD) undergoing ventricular assist device (VAD) implantation.
Objectives: This study sought to evaluate differences in VAD outcomes for children with CHD to those with non-CHD as well as those with univentricular CHD to those with biventricular CHD.
Methods: Data for CHD and non-CHD patients from the multicenter ACTION (Advanced Cardiac Therapies Improving Outcomes Network) undergoing VAD implantation from April 2018 to February 2023 were included.
J Am Coll Cardiol
November 2024
British Heart Foundation Centre of Research Excellence, the University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Background: Myocardial fibrosis is a key healing response after myocardial infarction driven by activated fibroblasts. Gallium-68-labeled fibroblast activation protein inhibitor ([Ga]-FAPI) is a novel positron-emitting radiotracer that binds activated fibroblasts.
Objectives: The aim of this study was to investigate the intensity, distribution, and time-course of fibroblast activation after acute myocardial infarction.
J Am Coll Cardiol
November 2024
Elite Centre for Individualized Medicine in Arterial Disease, Odense University Hospital, Odense, Denmark; Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Background: Prospective data on the clinical course of the ascending thoracic aorta are lacking.
Objectives: This study sought to estimate growth rates of the ascending aorta and to evaluate occurrences of adverse aortic events (AAEs)-that is, thoracic aortic ruptures, type A aortic dissections, and thoracic aortic-related deaths.
Methods: In this prospective cohort study from the population-based, multicenter, randomized DANCAVAS (Danish Cardiovascular Screening trials) I and II, participants underwent cardiovascular risk assessments including electrocardiogram-gated, noncontrast computed tomography (CT) scans.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!